is a frequent cytogenetic abnormality found in approximately 40% of SMZL cases. 4. Clinical Presentation and Complications

To assist you with your request regarding (lymphomes spléniques), I have outlined a structured academic-style paper based on current hematopathological classifications and clinical guidelines.

Search for "Splenic Marginal Zone Lymphoma guidelines."

Currently considered the first-line standard of care, offering high response rates with low toxicity.

For patient-oriented and clinical summaries.